These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress. Young LA; O'Connor LO; de Renty C; Veldman-Jones MH; Dorval T; Wilson Z; Jones DR; Lawson D; Odedra R; Maya-Mendoza A; Reimer C; Bartek J; Lau A; O'Connor MJ Cancer Res; 2019 Jul; 79(14):3762-3775. PubMed ID: 31123088 [TBL] [Abstract][Full Text] [Related]
3. The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors. Parsels LA; Parsels JD; Tanska DM; Maybaum J; Lawrence TS; Morgan MA Cell Cycle; 2018; 17(9):1076-1086. PubMed ID: 29895190 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy. Guertin AD; Li J; Liu Y; Hurd MS; Schuller AG; Long B; Hirsch HA; Feldman I; Benita Y; Toniatti C; Zawel L; Fawell SE; Gilliland DG; Shumway SD Mol Cancer Ther; 2013 Aug; 12(8):1442-52. PubMed ID: 23699655 [TBL] [Abstract][Full Text] [Related]
5. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade. Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma. Russell MR; Levin K; Rader J; Belcastro L; Li Y; Martinez D; Pawel B; Shumway SD; Maris JM; Cole KA Cancer Res; 2013 Jan; 73(2):776-84. PubMed ID: 23135916 [TBL] [Abstract][Full Text] [Related]
7. PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer. Jhuraney A; Woods NT; Wright G; Rix L; Kinose F; Kroeger JL; Remily-Wood E; Cress WD; Koomen JM; Brantley SG; Gray JE; Haura EB; Rix U; Monteiro AN Mol Cancer Ther; 2016 Jul; 15(7):1669-81. PubMed ID: 27196765 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the Iannuzzi CA; Indovina P; Forte IM; Di Somma S; Malfitano AM; Bruno M; Portella G; Pentimalli F; Giordano A Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33020398 [TBL] [Abstract][Full Text] [Related]
9. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer. Sen T; Tong P; Diao L; Li L; Fan Y; Hoff J; Heymach JV; Wang J; Byers LA Clin Cancer Res; 2017 Oct; 23(20):6239-6253. PubMed ID: 28698200 [No Abstract] [Full Text] [Related]
10. Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy. Matheson CJ; Casalvieri KA; Backos DS; Reigan P ChemMedChem; 2018 Aug; 13(16):1681-1694. PubMed ID: 29883531 [TBL] [Abstract][Full Text] [Related]
11. Wee1 kinase as a target for cancer therapy. Do K; Doroshow JH; Kummar S Cell Cycle; 2013 Oct; 12(19):3159-64. PubMed ID: 24013427 [TBL] [Abstract][Full Text] [Related]
12. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint. Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer. Ha DH; Min A; Kim S; Jang H; Kim SH; Kim HJ; Ryu HS; Ku JL; Lee KH; Im SA Sci Rep; 2020 Jun; 10(1):9930. PubMed ID: 32555285 [TBL] [Abstract][Full Text] [Related]
14. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. Ghelli Luserna di Rorà A; Cerchione C; Martinelli G; Simonetti G J Hematol Oncol; 2020 Sep; 13(1):126. PubMed ID: 32958072 [TBL] [Abstract][Full Text] [Related]
15. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Lindemann A; Patel AA; Tang L; Tanaka N; Gleber-Netto FO; Bartels MD; Wang L; McGrail DJ; Lin SY; Frank SJ; Frederick MJ; Myers JN; Osman AA Mol Cancer Ther; 2021 Jul; 20(7):1257-1269. PubMed ID: 33947685 [TBL] [Abstract][Full Text] [Related]